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Abstract
Background: Major depressive disorder (MDD) is associated with chronic biases in the allocation of attention and
recollection of personal memories. Impaired flexibility in attention and autobiographical memory retrieval is seen to
both maintain current symptoms and predict future depression. Development of innovative interventions to reduce
maladaptive cognitive patterns and improve cognitive flexibility in the domain of memory may therefore advance
current treatment approaches for depression. Memory specificity training and cognitive bias modification techniques
have both shown some promise in improving cognitive flexibility. Here we outline plans for a trial of an innovative
memory flexibility training programme, MemFlex, which advances current training techniques with the aim of
improving flexibility of autobiographical memory retrieval. This trial seeks to estimate the efficacy of MemFlex,
provide data on feasibility, and begin to explore mechanisms of change.
Methods/design: We plan a single-blind, randomised, controlled, patient-level trial in which 50 individuals
with MDD will complete either psychoeducation (n = 25) or MemFlex (n = 25). After completing pre-treatment
measures and an orientation session, participants complete eight workbook-based sessions at home. Participants will
then be assessed at post-treatment and at 3 month follow-up. The co-primary outcomes are depressive symptoms and
diagnostic status at 3 month follow-up. The secondary outcomes are memory flexibility at post-treatment and number
of depression free days at 3 month follow-up. Other process outcomes and mediators of any treatment effects will also
be explored.
Discussion: This trial will establish the efficacy of MemFlex in improving memory flexibility, and reducing depressive
symptoms. Any effects on process measures related to relapse may also indicate whether MemFlex may be helpful in
reducing vulnerability to future depressive episodes. The low-intensity and workbook-based format of the programme
may improve access to psychological therapies, and, if encouraging, the results of this study will provide a platform for
later-phase trials.
Trial registration: NCT02371291 (ClinicalTrials.gov), registered 9 February 2015.
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Background
Major depressive disorder (MDD) runs a chronic and
unrelenting course. While current treatments for depres-
sion are effective, rates of relapse are high, with more
than 80 % of sufferers experiencing future episodes [1].
Attention has therefore turned to how best to enhance
and advance current therapeutic practice in order to re-
duce relapse. Along with the stereotypical symptom of
low mood, depression is associated with a range of cogni-
tive impairments [2]. In particular, depression is associated
with fixed, habitual biases in the allocation of attention
and recollection of personal memories. Chronic cognitive
bias, or reduced cognitive flexibility, is seen to both
maintain current symptoms and predict future depres-
sion [3, 4]. Development of innovative interventions to
reduce maladaptive cognitive patterns and improve
cognitive flexibility may therefore advance current
treatment approaches for depression [3, 5, 6].
Cognitive flexibility is a key contributor to daily well-
being. The absence of flexibility is linked to a number of
different psychopathologies [7], and is an integral feature
of depression [8]. Rigid and automatic cognitive bias is
most prominent in attending to and remembering infor-
mation [9]. When attending to information, depressed
individuals demonstrate negative inferences about am-
biguous material [6], preferential bias towards negative
stimuli [3, 6], and a chronic tendency towards negative
attributions of the self and world [10]. When remember-
ing information, depressed individuals demonstrate a
lack of flexibility in moving between general and specific
personal memories [11] and, subsequently, impaired re-
trieval of specific memories [4]. Attention and memory
biases also appear to combine to produce a bias toward
the recall of negative information [12]. As rigid cognitive
patterns continue to be observed once depression has
remitted [13], a lack of cognitive flexibility is considered
a vulnerability factor for future depressive symptoms [6].
Empirical attention has therefore turned to interven-
tions that target cognitive flexibility. Attentional bias
has been primarily targeted though cognitive bias modi-
fication (CBM) [14]. CBM trains individuals to repeat-
edly engage with neutral or positive stimuli to reduce
the automaticity with which negative information is
attended to, thereby reducing negative bias. Originally
designed to reduce the tendency towards selective pro-
cessing of threatening information in anxiety, the tech-
nique has begun to be applied to depression-related
biases. Meta-analysis demonstrates a moderate effect of
CBM in reducing both attention and processing biases
in depressed samples [14]. Prior research has also sug-
gested a positive impact of CBM on depressive symp-
toms (e.g. [15]). Though further research is needed,
CBM may hold some promise for targeting attention
bias in depressed samples.
Changing the nature of retrieved autobiographical
(i.e. personal) memories has been the primary target for
memory-based interventions. Autobiographical memor-
ies may be recalled as specific memories, and refer to
one particular event (e.g. having dinner on my birthday
this year), or general memories, which summarise cat-
egories of events (e.g. my birthday parties). Depressed
individuals consistently demonstrate reduced recall of
specific memories in cued retrieval tasks, which in turn
predicts depression symptoms up to a year later (for re-
view see [16]). Reduced specificity also reduces every-
day skills such as problem solving [17] and the ability
to readily imagine future events (which is critical for
planning) [18]. Memory specificity training therefore aims
to improve access to specific memories by educating the
participant about the different types and roles of autobio-
graphical memories, and giving them repeated practice in
recalling specific memories.
Current evidence for the likely efficacy of training
enhanced specificity is promising. The initial training
programme devised by Raes and colleagues [19] improved
depressive symptoms in a sample of inpatients in an un-
controlled trial. In the first randomised controlled study,
Neshat-Doost et al. [20] also demonstrated that bereaved
adolescents who completed 5 weeks of memory specificity
training experienced fewer symptoms of depression at
2 month follow-up compared to a control condition. Fur-
ther, the impact of training on depressive symptoms at
follow-up was mediated by improvement in memory spe-
cificity. Training has also proved successful in those with
post-traumatic stress disorder (e.g. [21]), suggesting po-
tential transdiagnostic effects. There are currently further
evaluations of memory specificity training underway
(e.g. [22]); however, these initial findings indicate that
targeting reduced specificity shows promise in alleviat-
ing depressive symptoms.
The bias toward negative memories, and correspond-
ing reduced access to positive memories, has also re-
ceived some attention in interventions. In depressed
samples, negative memories are recalled more often than
positive memories [12] which contributes to the perva-
sively negative view of the self and world [9]. When posi-
tive memories are recalled, they are less vivid [23, 24], and
have a reduced impact on affect [25, 26]. Recall of positive
memories is a key technique in regulating negative affect
[27] and, as such, reduced access and quality of positive
memories is likely to impact mood regulation. CBM
techniques for reducing negative attentional bias have
begun to be adapted for memory retrieval in depressed
samples, and have been seen to reduce negative gener-
alisation and depressive symptoms [28, 29]. Novel ap-
proaches toward bias reduction have also emerged. The
Method-of-Loci technique has been successfully used as a
mnemonic device to facilitate the recall of elaborated
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positive memories in depressed samples [30]. Reduction
of bias toward negative memories and enrichment of posi-
tive memories through the adaptation of existing memory
therapeutics is therefore likely to aid cognitive flexibility
and, in turn, psychological wellbeing.
In sum, depressed individuals demonstrate cognitive
inflexibility in their attention to emotional information,
along with retrieval of autobiographical memories. Biases
in these cognitive processes can be durable cognitive
markers of depression, and are related to symptom se-
verity. Previous interventions have yielded positive re-
sults, and suggest that training cognitive flexibility may
reduce current symptoms. However, current training
techniques could be enhanced to improve treatment ef-
fects. For example, it is not only impaired recall of spe-
cific memories but also the ability to alternate between
specific and general memories that relates to depression
symptoms [11]. Improving access to specific memories
through memory specificity training may influence flex-
ible movement between memory types; however, further
direct training of this skill may more effectively improve
cognitive flexibility. In addition, flexibility training could
be advanced to simultaneously target both the negative
and general memory bias, rather than training these
skills through separate programmes. This would reduce
treatment duration, more holistically train cognitive
flexibility, and potentially achieve greater improvement
in depressive symptoms. Finally, cognitive models of de-
pression indicate that improved flexibility may reduce
the risk of relapse by improving daily functioning skills
such as problem solving and mood regulation techniques.
However, mechanisms underlying flexibility training have
yet to be comprehensively explored. This proposed trial
aims to advance current training practices by addressing
each of these issues.
We plan to evaluate a novel cognitive intervention,
MemFlex. The MemFlex programme combines CBM
techniques and memory specificity training to simul-
taneously target multiple cognitive biases and thereby
improve flexibility in three key areas: 1) reducing bias
toward negative information in memory and attention; 2)
improving the quality of positive memories by encour-
aging memory elaboration; and 3) encouraging flexible
movement between general and specific autobiograph-
ical memories. We compare MemFlex to a psychoedu-
cation control condition in a sample of depressed
British adults to establish the efficacy and feasibility of
MemFlex. We also provide a preliminary examination
of whether MemFlex may impact everyday processes
such as problem solving, rumination, and cognitive
avoidance, and if changes in these processes may underlie
treatment effects. In doing so, we address three key
questions. First, does MemFlex improve memory flexi-
bility and reduce depression symptoms? Second, is any
improvement superior to that achieved by a psychoedu-
cation intervention? Finally, what are the likely mecha-
nisms mediating any treatment effects? We hypothesise
a significant effect of treatment condition on our co-
primary outcome variables of depressive symptoms and
depression status at 3 month follow- up. Specifically,
we predict that participants in the MemFlex condition
will exhibit fewer depressive symptoms, and be less
likely to meet criteria for a major depressive episode
than those in the psychoeducation condition. We also
hypothesise that participants in the MemFlex condition
will demonstrate increased flexibility in memory retrieval
at post-treatment and a greater number of depression-free
days at 3 month follow-up, relative to the psycheducation
control, as secondary outcomes.
Methods/design
Study design
The design is a single-blind, patient-level, randomised con-
trolled trial (RCT) comparing MemFlex to psychoeduca-
tion. Each condition will comprise a 4-week programme,
consisting of an initial face-to-face session, followed by
4 weeks to complete a self-guided workbook. Participants
will be assessed pre-treatment, post-treatment, and at a
3 month follow-up. Upon completion of the 3 month
follow-up, those in the psychoeducation condition will be
given access to the MemFlex materials. The co-primary
outcome measures will be depressive symptoms and diag-
nostic status at 3 month follow-up.
Participants and recruitment
We will recruit 25 participants per condition (n = 50) with
a primary diagnosis of MDD. Inclusion criteria are age
over 18 years and currently experiencing a major depres-
sive episode, as assessed using the Structured Clinical
Interview for the Diagnostic and Statistical Manual
(DSM)-IV (SCID) [31]. Participants will be excluded if
their SCID assessment indicates they are experiencing
another mood disorder, psychosis, or current alcohol or
substance dependence/abuse. Those with a diagnosed per-
sonality disorder or brain injury (assessed by participant
report) will also be excluded.
Participants will be recruited in three ways. First, we
will recruit from the community via posters and adver-
tisements. Potential participants who make contact after
seeing an advertisement will be sent an information
sheet. If consent to contact is given, we will then tele-
phone the individual to complete an initial telephone
screening. Second, we will recruit from our department
volunteer database, which consists of approximately 300
volunteers who have a history of depression and have
expressed a wish to participate in research into the dis-
order. Those on the database will be emailed the study
information sheet, and directed to contact the research
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team if they would like to participate. Again, those inter-
ested in participating will then complete an initial tele-
phone screening. Finally, we will also recruit those from
clinical facilities who have given consent to be contacted
regarding participation in depression research. Recruit-
ment of these participants will follow the same procedure
as our database. Following the initial telephone screening,
all eligible participants will be invited to complete a SCID
and the pre-treatment assessment.
Participant allocation
Random allocation to condition using computer-generated,
quasi-random numbers will be completed by the trial stat-
istician (PW), who is blind to study objectives. Once a par-
ticipant has completed the pre-treatment assessment, the
researcher completing the initial session will be informed
of condition allocation. This process is demonstrated in
the CONSORT diagram in Fig. 1.
Interventions
MemFlex
The MemFlex programme draws on CBM and memory
specificity training techniques [19, 22]. MemFlex is pri-
marily self-guided and covers three key memory skills to
reduce autobiographical memory biases associated with
depression. These skills are summarized as 'balancing',
'elaboration', and 'flexibility'. The training material is
presented over one face-to-face introductory session and
eight self-guided sessions. The initial face-to-face session
is completed with a researcher at the research centre. In
this session the researcher provides an introduction to
different memory systems (e.g. working memory versus
autobiographical memory), and outlines the importance
of autobiographical memory in everyday life. The impact
of depression on autobiographical memory is covered,
along with the different types of autobiographical mem-
ories (e.g. specific, general). The researcher introduces
cued–recall tasks which are used throughout the work-
book, and guides the participant in completion of these
tasks. When understanding of the basic principles is satis-
factory, the researcher assists the participant to set a
schedule for completion of the workbook over the follow-
ing 4 weeks. Participants will receive weekly emails during
this period encouraging them to complete the workbook.
They will also receive a telephone call from a team mem-
ber at the beginning of week 3 to check progress, and
clarify any difficulties with the workbook material.
Session 1 of the workbook reviews the material covered
in the face-to-face session, and introduces the 'balancing'
skill. Balancing refers to improving access to both specific
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Fig. 1 CONSORT diagram
Hitchcock et al. Trials  (2015) 16:494 Page 4 of 8
and general memories of neutral and positive valence. Fol-
lowing a description of the skill, the participant is given
practice retrieving positive and neutral memories. As de-
pression is consistently associated with prolific retrieval of
negative and general autobiographical memories, we focus
on improving access to other autobiographical memories.
Session 2 introduces 'elaboration'; that is, enriching the
detail of recalled memories and improving access to the
emotion attached to the memory. Again, once the skill is
introduced, the participant is given practice elaborating
positive memories. Session 3 consolidates previous skills,
before 'flexibility' is introduced in Session 4. The flexibility
skill helps participant to move between specific and gen-
eral memories. Sessions 5 to 8 give participants practice in
using the different skills, and aim to develop automaticity
of the retrieval processes. In addition to completing the
sessions in the workbook, individuals are required to prac-
tice generative memory retrieval multiple times a day.
We have previously evaluated the feasibility of MemFlex
with a group of 38 individuals with a history of MDD but
currently in remission. Based on feedback from those indi-
viduals, the workbook was refined, and expanded from six
to eight sessions. The revised workbook was then sub-
jected to a final feasibility evaluation with three individuals
with a current diagnosis of MDD. No further changes
were made.
Psychoeducation
Similar to the intervention condition, participants in the
psychoeducation condition will also complete an initial
face-to-face session. This session will cover the symp-
toms and causes of depression, and the workbook will
be introduced. As in the MemFlex condition, the work-
book will consist of eight self-guided sessions that the
individual will be required to complete over 4 weeks.
Participants will receive weekly emails during this period
encouraging them to complete the workbook. They will
also receive a telephone call from a team member at the
beginning of week 3 to check progress, and clarify any
difficulties with the workbook material.
The workbook content will cover the presentation of
depression and basic information on factors associated
with depression, such as worry, procrastination, and
sleep difficulties. Each session will consist of information
on the psychological theory concerning the topic, and an
explanation of the impact of the identified factor on de-
pressive symptoms. This will be illustrated with exam-
ples. Each session will also include a series of questions
about the material to ensure participant engagement.
The workbook content was developed by clinical psy-
chologists (CH and TD). Two additional clinical psycholo-
gists independent of the study were consulted regarding
the suitability of the workbook material, and their recom-
mended refinements were made. An internal pilot of the
workbook was completed with the first three participants
allocated to the psychoeducation condition. No further
amendments were made.
Treatment integrity
Initial face-to-face sessions will be manualised and will
be completed by clinical staff. All staff will be trained in
the administration of the session by a clinical psycholo-
gist (CH), who will also provide ongoing supervision. A
fidelity checklist will be completed by the therapist at
the end of each individual session to assess adherence to
the manual. Sessions will also be audio-recorded, and
15 % of these will be independently rated for adherence
to the manual. A 2-week extension will be granted if the
workbook is not completed within the set 4-week period.
That is, up to 6 weeks will be allowed for completion of
the workbook. To determine adherence, the researcher
will review the workbook at the post-treatment assess-
ment, and record the number of sessions the participant
has completed. This will inform our understanding of
the acceptability and feasibility of the programme.
Measures
Primary outcomes
The co-primary outcomes are depressive symptoms at
3 month follow-up, as reported on the Beck Depression
Inventory II (BDI-II), and diagnostic status at 3 month-
follow-up, which will be measured using the Longitu-
dinal Interval Follow-up Evaluation of the SCID [31].
Secondary outcomes
Of secondary interest is the number of depression-free
days since post-treatment, which will be measured at
3 month follow-up using the Longitudinal Interval
Follow-up Evaluation of the SCID [31]. We are also in-
terested in the flexibility of autobiographical retrieval
at post-treatment, measured using the Autobiographical
Memory Task (AMT) with Alternating Instructions [11].
As MemFlex aims to improve the flexibility with which an
individual can move between specific and general memor-
ies, we used an alternating instruction AMT (AMT-AI),
rather than the traditional AMT [32], which indexes the
retrieval of specific memories alone. The AMT-AI re-
quires participants to retrieve specific memories to a block
of six cue words, general memories for a block of six cues,
and finally a block of twelve cues in which the individual
must alternate between retrieval of specific and general
memories. Order of the specific and general blocks is ran-
domised between participants. Cues are of positive, nega-
tive, and neutral valence, and are also randomised to
block. The number and proportion of correct responses is
calculated for each block (i.e. specific, general, alternating).
The total number of correct responses and the number of
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correct responses in the alternating block will be used as
the main outcome variables.
Process measures
We will also consider mechanisms through which
MemFlex may impact depressive symptoms. Potential
mechanisms have been drawn from previous evidence
of processes mediating the effect of autobiographical
memory on depression (reviewed in [33]). These pro-
cesses include: 1) problem solving, measured using the
short version of the Means-Ends Problem Solving task
[34]; 2) rumination, which will be assessed using the
Rumination Response Scale [35]; 3) cognitive avoidance,
indexed by the Cognitive Avoidance Questionnaire [36];
and 4) verbal fluency as a measure of executive control, as
indexed by the Verbal Fluency Task [37]. Each of these
measures possesses adequate psychometric properties and
has been previously used in evaluation of autobiographical
memory interventions. Parallel forms of these measures
will be administered at pre- and post-treatment, allowing
us to determine whether change in these factors mediates
the effect of MemFlex on depressive symptoms at follow-
up.
Methodological aspects
Power analysis and sample size
Although a standard power calculation based on detecting
treatment effects would be the conventional approach to
determining sample sizes for clinical trials, the main aim
of the current Phase II trial is to provide a point-estimate
of efficacy, and evaluate acceptability and feasibility of
MemFlex, in preparation for later phase evaluations of the
intervention in line with UK Medical Research Council
(MRC) guidance. Our previous experience with Phase II
exploratory trial platforms indicates that 50 participants
(25 in each arm) will provide sufficient numbers to esti-
mate outcome, and evaluate feasibility and acceptability,
and to generate preliminary process data for this treatment.
This will provide a plausible range of point estimates of
effect on our set of outcome measures sufficient to guide
us in sample size calculations for later phase trial work.
Data collection
All participants will complete assessments at pre-treatment,
post-treatment, and at 3 month follow-up. All mea-
sures will be administered face-to-face at pre- and post-
treatment. The follow-up assessment will involve symptom
measures only and will be administered either in person or
over the telephone. Assessments will be completed by
clinical research staff under the supervision of a clinical
psychologist (CH). Inter-rater reliability will be completed
for the AMT-AI to ensure high data quality. Data will be
securely stored in de-identified form onsite.
Blinding
The study will employ a single-blind design. This will be
achieved by condition allocation not being revealed until
the pre-treatment assessment has been completed. Post-
treatment and follow-up assessments will be completed
by a blinded assessor.
Statistical analysis plan
All analyses will be completed by the trial statistician, in
accordance with CONSORT guidelines. The effect of
treatment condition (MemFlex, psychoeducation) on our
co-primary outcome of the number of participants who
meet criteria for a major depressive episode at follow-up
will be determined using chi square analysis. The effect
of treatment condition on our co-primary outcome of
the number of depressive symptoms at follow-up and on
our secondary outcomes will be analysed using inde-
pendent samples t-tests. Baseline differences on relevant
measures will be included as covariates, if appropriate.
We will also examine mediation effects to determine any
mechanisms of change. Assessment of mediation will be
completed according to recommendations of Hayes [38].
Multiple imputation will be used to account for missing
data. Intent-to-treat analysis will also be used for those
lost to attrition. No interim analyses are to be completed.
Monitoring and data management
This trial will be completed at the MRC Cognition and
Brain Sciences Unit in Cambridge. Data checks will be
completed by the trial coordinator (CH) to ensure data
quality. As this study is an exploratory trial, an independ-
ent data monitoring committee was not deemed neces-
sary. All management will be completed by the trial lead
(TD), trial coordinator (CH), and trial statistician (PW).
Safety aspects
No adverse events are anticipated as a result of the study.
However, as all participants will be clinically depressed,
there is risk of suicidality and self-harm. This will be mon-
itored using clinical judgement and structured risk assess-
ment. Both the trial lead (TD) and coordinator (CH) are
clinical psychologists experienced in the treatment and
management of depression, and will adhere to MRC safety
protocols if adverse events do occur.
Ethics and dissemination
All participants will provide informed consent prior to par-
ticipating in the study. Ethics approval has been granted
by the UK National Research Ethics Committee (East of
England, 11/H0305/1). MRC, National Health Service and
professional ethical guidelines will be adhered to through-
out the study. No restrictions have been placed on the
publication of results.
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Discussion
Due to high relapse rates for depression, clinical research
has begun to target cognitive vulnerabilities which may
predispose the individual to future episodes. The flexibility
of attention and memory represent well-established vul-
nerabilities, and previous interventions in this area have
been promising (e.g. [20, 29]). The MemFlex programme
aims to expand existing interventions by simultaneously
targeting multiple inflexibilities, and by beginning to ex-
plore the mechanisms through which the flexibility of
memory retrieval impacts depressive symptoms. The pro-
posed RCT also advances the field by offering a self-
guided, non-computer-based version of flexibility training.
This format may engage individuals who may not commit
to face-to-face therapy, and the low intensity programme
may help to improve depressive symptoms to a point
where more intensive therapy, such as cognitive behav-
ioural therapy (CBT), may be completed. Relative to group
or one-to-one work, self-guided work may also be more
easily offered as an adjunct to CBT, or in situations when
access to trained mental health care workers is limited.
Coupled with the reduced cost of administration, this in-
creases accessibility of treatment, and may see that the
programme is both more affordable and more accessible
than existing training options.
Evaluation of novel and innovative treatments is vital in
optimising the accessibility of evidence-based interven-
tion, and meeting the aims of the Improving Access to
Psychological Treatment initiative in the United Kingdom.
If the clinical promise of MemFlex can be established,
this trial will be a platform for a larger scale RCT. A
Phase III trial will allow us to definitively determine the
size of treatment effects, and more comprehensively
examine the mechanisms underlying these effects. Novel
and innovative intervention options present an exciting
avenue for research with clinical samples, and such work
may ultimately lead to improved accessibility of psycho-
logical treatment.
Trial status
Recruitment began in January 2015.
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